Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Pressure-enabled Delivery in Radioembolization (TriNav Study) [NA]
The TriNav study, led by Massachusetts General Hospital, is evaluating pressure-enabled delivery in radioembolization for liver cancers; the…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE [Phase 2]
Phase 2 clinical trial evaluating transarterial radioembolization with durvalumab and bevacizumab for unresectable hepatocellular carcinoma;…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients [NA]
A clinical trial comparing endoscopic ultrasound-guided therapy with conventional endoscopic therapy to prevent variceal rebleeding in patie…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating atezolizumab and bevacizumab with SRF388 or placebo in hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors [NA]
This document outlines a prospective clinical validation trial using next-generation sequencing and patient-derived tumor organoids to guide…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Safety and Efficacy of LVD + C-TACE + Tis/Len for Unresectable Right-Liver HCC [NA]
A clinical trial update evaluating the safety and efficacy of LVD + C-TACE + Tis/Len for unresectable hepatocellular carcinoma; the study is…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma [Phase 2]
A Phase 2 prospective clinical trial is evaluating safety and efficacy of a triplet therapy (Irpagratinib, atezolizumab, and bevacizumab) in…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II) [Phase 1, Phase 2]
Phase I/II trial of MRG006A in combination therapy for advanced hepatocellular carcinoma; the study status is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study [NA]
A multicenter randomized controlled trial evaluating whether Fufang Biejiaruangan plus antiviral therapy reduces hepatocellular carcinoma in…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study of SHR-2524 Plus Bevacizumab in the First-line Treatment of Advanced Hepatocellular Carcinoma [Phase 1]
This is a Phase 1 study evaluating SHR-2524 in combination with bevacizumab as first-line therapy for advanced unresectable hepatocellular c…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab [NA]
This clinical trial update reports ongoing research to identify biomarkers that predict outcomes for hepatocellular carcinoma patients treat…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC. [Phase 2]
A Phase II clinical trial update indicates the combination of AK104 and AK112 with TT-00420 tablet for advanced hepatocellular carcinoma is …
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients [Phase 1, Phase 2]
An ongoing phase 1/2 pediatric trial examines safety and potential efficacy of a four-drug combination (cyclophosphamide, sorafenib, bevaciz…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating the addition of a telomerase-derived CD4 Th1-inducer cancer vaccine to atezolizumab plus bevacizumab in unresectabl…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Study of Neoadjuvant Tislelizumab Plus Lenvatinib in Resectable HCC at High Risk of Recurrence [Phase 3]
This is a Phase 3 clinical trial update on neoadjuvant tislelizumab plus lenvatinib for resectable hepatocellular carcinoma at high risk of …
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma [Phase 1]
Phase I trial evaluating pharmacokinetics, safety, efficacy and immunogenicity of the ipilimumab biosimilar HLX13 versus YERVOY in first-lin…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis [NA]
This clinical trial update describes a program in the Central Denmark Region that offers biannual ultrasound and alpha-fetoprotein screening…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver [Phase 4]
Phase 4 clinical trial investigating pregabalin for postoperative analgesia during radiofrequency ablation of focal liver lesions in hepatoc…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial update describing a pilot study of prednisone for liver protection in patients with hepatocellular carcinoma receivin…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Stereotaxic Irradiation of Hepatocellular Carcinoma [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating stereotaxic irradiation for hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response [NA]
A terminated clinical trial (NCT02439008) investigating early biomarkers of tumor response to high-dose hypofractionated radiotherapy across…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Safety and Efficacy of Atezolizumab-Bevacizumab Versus Tyrosin Kinase Inhibitors in Patients With Liver Cirrhosis
A completed clinical trial assesses safety and efficacy of the atezolizumab‑bevacizumab combination versus tyrosine kinase inhibitors in pat…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors [Phase 1]
A Phase 1 study evaluating Zanzalintinib in combination with immuno-oncology agents in patients with various solid tumors; recruitment is on…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer. [NA]
A clinical trial update indicates FAST-IRM is being studied for hepatocellular carcinoma surveillance in high-risk liver cancer patients and…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion
Clinical trial update evaluating hepatic arterial infusion chemotherapy with lenvatinib and a PD-1 inhibitor for advanced hepatocellular car…